8-K/A: Infleqtion Amends 8-K, Reveals Strong 2025 Revenue Growth

Infleqtion, Inc. filed an amendment to its 8-K, providing audited financial statements and management's discussion for ColdQuanta, Inc. (Legacy Infleqtion) for 2024 and 2025, highlighting significant revenue growth and strategic advancements ahead of its Business Combination.

Summary

• Amendment No. 1 to Form 8-K was filed to include audited financial statements and Management's Discussion and Analysis (MD&A) for ColdQuanta, Inc. (Legacy Infleqtion) for the years ended December 31, 2025 and 2024.
• The Business Combination with Churchill Capital Corp X (CCX) closed on February 13, 2026, with Infleqtion being the accounting acquirer in a reverse recapitalization.
• Infleqtion received approximately $551.4 million in gross transaction proceeds from the Business Combination, significantly strengthening its liquidity.
• Total revenue increased by 13% to $32.5 million in 2025, up from $28.8 million in 2024, primarily driven by a 97% increase in service revenue.
• Net loss decreased by 41% to $31.8 million in 2025, compared to $53.8 million in 2024.
• Gross profit increased by 30% to $11.8 million in 2025, from $9.1 million in 2024.
• Net cash used in operating activities decreased by $8.4 million to $24.1 million in 2025, from $32.5 million in 2024.
• The company incurred an accumulated deficit of $231.1 million as of December 31, 2025.
• Significant contract awards in 2025 include a $17.0 million NASA contract modification for a Quantum Gravity Gradiometer, a $2.0 million U.S. Army contract for Linchpin AI, and $6.2 million in U.S. Department of Energy's Advanced Research Projects Agency-Energy (ARPA-E) funding.
• Strategic partnerships were announced in late 2025 with Safran Electronics & Defense, Voyager Technologies, and NVIDIA to advance quantum technology and expand market access.
• Infleqtion completed its final Series C convertible redeemable preferred stock offering in May 2025, raising approximately $100 million in aggregate gross proceeds.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive update, reflecting improved financial performance (reduced losses, revenue growth) and a significantly strengthened capital position post-Business Combination, despite ongoing operational losses.

Positives

• Total revenue increased by 13% to $32.5 million in 2025, up from $28.8 million in 2024.
• Gross profit increased by 30% to $11.8 million in 2025, compared to $9.1 million in 2024.
• Net loss significantly decreased by 41% to $31.8 million in 2025, from $53.8 million in 2024.
• Loss from operations decreased by 33% to $35.3 million in 2025, from $53.0 million in 2024.
• Net cash used in operating activities decreased by $8.4 million to $24.1 million in 2025, from $32.5 million in 2024.
• The successful closing of the Business Combination with Churchill Capital Corp X on February 13, 2026, brought approximately $551.4 million in gross transaction proceeds, significantly strengthening the company's liquidity.
• Secured significant contract awards in 2025, including a $17.0 million NASA contract modification, a $2.0 million U.S. Army contract, and $6.2 million in DOE ARPA-E funding.
• Established strategic partnerships with Safran Electronics & Defense, Voyager Technologies, and NVIDIA to advance quantum technology and expand market access.
• Completed Series C convertible redeemable preferred stock offering in May 2025, raising approximately $100 million in gross proceeds.
• Generative AI (GenAI) adoption has significantly enhanced productivity, particularly for software engineering.
• No impairment charges were recorded in 2025, compared to $13.5 million in 2024.

Negatives

• Product revenue decreased by 12% to $19.6 million in 2025, from $22.3 million in 2024.
• The company has incurred net losses and used cash in operating activities since inception, with an accumulated deficit of $231.1 million as of December 31, 2025.
• Cash and cash equivalents (including restricted cash) decreased significantly to $11.9 million as of December 31, 2025, from $48.1 million as of December 31, 2024 (prior to Business Combination proceeds).
• Net cash used in investing activities was $53.5 million in 2025, primarily due to $56.8 million in available-for-sale securities purchases.
• Expiration of UK government contracts resulted in a $6.8 million decrease in revenue in 2025.
• Completion of the Quantum Moonshot program with Japan Science and Technology Association led to a $3.5 million decrease in revenue in 2025.
• The company expects to incur increased ongoing costs related to public company reporting, governance, and compliance requirements.
• Selling, general and administrative expenses increased by $4.1 million due to changes in the fair value of a contingent obligation and $3.7 million in accounting fees in 2025.

Risks

• Dependence on the ability to demonstrate technological feasibility of products and services, as well as successful research and development of quantum technology.
• Risk of technology obsolescence due to rapid advancements in quantum technologies, necessitating additional investments.
• Challenges in integrating new technologies into existing capabilities, such as compatibility issues.
• A significant portion of business is conducted with governments, making financial performance susceptible to changes in procurement policies, budget considerations, and political developments.
• The company is subject to periodic compliance audits by the U.S. and U.K. governments.
• Ability to grow revenue in future periods depends on securing new government contracts and follow-on awards to replace or expand upon expiring programs.
• Future capital requirements are uncertain and depend on factors like customer attraction, market acceptance, contract timing, product development, and general economic conditions.
• Additional financing may not be available on acceptable terms, or at all.
• Existing Net Operating Losses (NOLs) and Research and Development (R&D) credit carryforwards may be subject to limitations under Sections 382 and 383 of the Internal Revenue Code if an ownership change occurs.
• Concentration of credit risk: one customer represented 78% of total accounts receivable as of December 31, 2025; two customers represented 60% and 12% of total revenue for the year ended December 31, 2025.
• Exposure to foreign currency risk due to international operations and contracts.
• Potential for legal proceedings and claims incidental to the normal course of business (though none material currently).

Future Outlook

Infleqtion expects to continue incurring operating losses and higher operating expenses as it invests in the development and commercialization of its technologies. The company anticipates increased ongoing costs related to public company reporting, governance, and compliance requirements. Management believes that the cash on hand as of December 31, 2025, combined with the $551.4 million proceeds from the Business Combination, will be sufficient to meet working capital and capital expenditure requirements for at least 12 to 18 months from the filing date. Future capital requirements will depend on various factors, including customer acquisition, market acceptance, contract timing, and product development.

Management Comments

• Our vision is to harness the power of quantum to expand human potential.
• Our approach is grounded in an integrated quantum technology platform, from foundational technology to advanced hardware and propriety software, all built on neutral atoms, natures ideal qubits, which enable an adaptable, scalable and high-fidelity path to quantum advantage across multiple applications.
• Today, our high-performance quantum clocks and quantum radio frequency (RF) sensors are already delivering quantum advantage, such as sensing the world with superior precision relative to classical state-of-the-art systems, and unlocking new classes of national security and commercial applications.
• As of December 31, 2025, the Company has achieved 12 logical qubits.
• Across our technology organization, generative AI (GenAI) adoption has significantly enhanced productivity, particularly for software engineering as many of the mechanical aspects of software development have been replaced or accelerated by GenAI tooling, dramatically reducing the time required to complete repetitive, manual processes.
• Management believes this capital base enhances our ability to advance product innovation and pursue additional market opportunities, supporting our long-term growth strategy.
• Our product roadmap benefits significantly from external funding sources to advance the technological roadmap across quantum sensing and quantum computing as technological advances in these areas are funded as cost of sales of the respective programs rather than through internal research and development.
• We expect to continue to invest in research and development as a public company to fund these technological priorities and realize our goal of at-scale, fault-tolerant quantum computing.

Industry Context

StockSavvy.ai notes that Infleqtion's focus on quantum sensing, computing, and software, particularly with neutral atom technology, aligns with the growing global investment in quantum technologies for defense, AI, and cybersecurity. The strategic partnerships with major players like NVIDIA and SAIC, alongside significant government contracts from NASA and the U.S. Department of Defense, demonstrate a strong positioning within the emerging quantum industry, leveraging both public and private sector demand for advanced capabilities. The company's emphasis on deployable, field-ready solutions for real-world applications, such as GPS-denied environments, addresses critical needs in national security and aerospace, areas seeing increased strategic importance.

Comparison to Industry Standards

• Infleqtion's Sqale quantum computing system has demonstrated high fidelity (99.73% controlled-Z (CZ) gate) and features the industry's largest neutral atom array outside of a research institution.
• The company's quantum clocks and RF sensors are noted for delivering superior precision relative to classical state-of-the-art systems.
• The partnership with NVIDIA to deploy an NVQLink-enabled quantum supercomputing system at the Illinois Quantum & Microelectronics Park aims to create a unified architecture for real-time hybrid quantum-classical computing, addressing critical scalability challenges for quantum computing.
• The collaboration with Safran Electronics & Defense integrates Infleqtion's Tiqker quantum optical clock technology with Safran's trusted synchronization systems to enable a GPS-independent timing architecture, setting a new benchmark for secure, resilient, and ultra-precise timing capabilities.

Management Changes

Corporate Governance

Legal Proceedings

• Management is not aware of any pending or threatened litigation that could have a material impact on the consolidated financial statements as of December 31, 2025 and 2024.

Related Party Transactions

• University of Colorado-Boulder: The Company's Co-Founder and Chief Science Officer concurrently serves as a professor. The Company sponsors research projects and utilizes laboratory equipment, recognizing $0 in service revenue in 2025 ($0.1 million in 2024) and $0.1 million in cost of services in both years.
• University of Wisconsin-Madison: The Company's Chief Scientist for Quantum Information concurrently serves as a professor. The Company has a research agreement, recording $0.5 million of research and development expenses in each of 2025 and 2024. Total accrued liabilities of $0.3 million and $0.5 million were outstanding as of December 31, 2025 and 2024, respectively.
• SAIC: An investor in the Company's Series C-1 convertible redeemable preferred stock, also entered into a new go-to-market partnership in June 2025.
• Patent Attorney: A patent attorney, related to an officer of the Company, billed $0 in 2025 ($88 thousand in 2024) for patent legal services.
• Spouse of a Management Member: A consulting agreement for research and development and customer contracts resulted in payments of $190 thousand in 2025 and $41 thousand in 2024.
• Grant Dollens: A member of the Board of Directors and previous Interim Chief Financial Officer, provided financial and accounting services, receiving $213 thousand in 2025 and $45 thousand in 2024. Total accounts payable of $36 thousand was outstanding as of December 31, 2025.
• DRS Daylight Solutions, Inc. / Monarch Quantum: The Company engaged DRS Daylight Solutions, Inc. (and later Monarch Quantum, controlled by former Board member Mr. Day) for engineering and programming services. Total accounts payable of $1.8 million was outstanding as of December 31, 2025.
• Microchip Technology Inc.: The Company purchased laboratory equipment from Microchip Technology Inc., where Eric Bjornholt (appointed to the Board in December 2025) serves as CFO. Total accounts payable of $64 thousand was outstanding as of December 31, 2025.

Stakeholder Impact

• Shareholders: The Business Combination significantly increased the company's capital base, providing liquidity and funding for future growth, which is positive. However, existing shareholders of Legacy Infleqtion had their shares exchanged at a defined ratio.
• Employees: Workforce reductions in 2024 impacted payroll and compensation costs. Stock-based compensation remains a component of employee incentives.
• Customers (Government & Commercial): New contract awards and strategic partnerships indicate continued and expanded offerings in quantum sensing, computing, and AI, potentially benefiting customers with advanced solutions.
• Creditors: Improved liquidity post-Business Combination reduces immediate credit risk.
• Suppliers/Partners: Strategic partnerships with companies like SAIC, Safran, Voyager, and NVIDIA indicate strong collaboration and potential for increased business for partners.

Next Steps

• Infleqtion, Inc. will present its historical financial statements for all periods in future periodic reports filed with the SEC, beginning with the quarter ended March 31, 2026.
• The company expects to continue investing in research and development to fund technological priorities and realize its goal of at-scale, fault-tolerant quantum computing.
• The company plans to continue making investments in strategic acquisition opportunities.
• Annual minimum royalties under the WARF License Agreement are first due within the company's fiscal year 2026.

Key Dates

Recommendation

The filing reveals a significant improvement in Infleqtion's financial health, with a 41% reduction in net loss and 13% revenue growth in 2025. Crucially, the post-period Business Combination with Churchill Capital Corp X injected over $550 million in gross proceeds, substantially de-risking the company's liquidity and providing ample capital for its ambitious quantum technology roadmap. Strategic partnerships with industry leaders like NVIDIA and SAIC, coupled with major government contract wins (NASA, U.S. Army, DOE), validate Infleqtion's technological leadership and market traction in critical sectors. While operational losses persist, the substantial capital infusion and strategic momentum position Infleqtion for accelerated growth and market penetration in the high-potential quantum computing and sensing space, making it a compelling 'strong buy' for long-term investors.

Keywords

Quantum Technology, Quantum Computing, Quantum Sensing, Neutral Atoms, SEC Filing, 8-K/A, Financial Results, ColdQuanta, Infleqtion, Business Combination, SPAC, Churchill Capital Corp X, Government Contracts, Defense, Aerospace, AI, Cybersecurity, Superstaq, Tiqker, Sqale, NASA, ARPA-E, NVIDIA, Safran, Voyager Technologies, SAIC, Financial Performance, Revenue Growth, Net Loss, Liquidity, Capital Raise, Risk Factors, Corporate Governance